More on ZYME

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-1,500.0% Growth)
- Ratings (9.5 Score)
- Holders

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Zymeworks (NQ:ZYME)
Delayed: 23.14 --0 (-0%)
Prev. Close $23.14  
Open$23.53 
52 Wk High$ 
52 Wk Low$ 
Day High$23.59 
Day Low$22.65 
P/E N/A  
EPS$ 
Volume699,025 

Friends, Peers and Foes (?): RPRX, GLMD, RPTX, INM, KBLB (more...)

Jun 18, 2026 08:05 AM Gandeeva and Zymeworks partner on cryo-EM antibody structure work
Jun 18, 2026 08:00 AM Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery
Jun 16, 2026 05:25 AM Zymeworks (ZYME) Reiterated at Market Outperform by Citizens on ZW191 Efficacy Data
Jun 14, 2026 06:05 PM Zymeworks reports phase 1 data for cancer drug ZW191
Jun 14, 2026 06:05 PM Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
Jun 9, 2026 06:08 AM Truist Securities Assumes Zymeworks (ZYME) at Buy
Jun 3, 2026 06:52 AM H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME)
May 15, 2026 05:00 PM Form 4 Zymeworks Inc. For: May 13 Filed by: Schneider Paul R
May 15, 2026 04:55 PM Form 3 Zymeworks Inc. For: May 13 Filed by: Schneider Paul R
May 15, 2026 04:15 PM Form SCHEDULE 13G/A Zymeworks Inc. Filed by: Rubric Capital Management LP
View All Articles

Entities mentioned with ZYME

View All Entities